Received: from westeu12-emailsignatures-cloud.codetwo.com (13.93.42.39) by DB1PEPF000509F6.mail.protection.outlook.com (10.167.242.152) with Microsoft SMTP Server (version=TLS1_2, cipher=TLS_ECDHE_RSA_WITH_AES_256_GCM_SHA384) id 15.20.9891.9 via Frontend Transport; Fri, 8 May 2026 07:50:36 +0000 Received: from DB1PEPF000509F6.eurprd02.prod.outlook.com (2603:10a6:10:28c:cafe::4e) by DU2PR04CA0287.outlook.office365.com (2603:10a6:10:28c::22) with Microsoft SMTP Server (version=TLS1_3, cipher=TLS_AES_256_GCM_SHA384) id 15.20.9891.19 via Frontend Transport; Fri, 8 May 2026 07:50:36 +0000 Received: from DUZPR08CU001.outbound.protection.outlook.com (40.93.64.68) by westeu12-emailsignatures-cloud.codetwo.com with CodeTwo SMTP Server (TLS12) via SMTP; Fri, 08 May 2026 07:50:35 +0000 Received: from DB9PR02MB6697.eurprd02.prod.outlook.com ([fe80::2c1:6459:93f7:d2e4]) by DB9PR02MB6697.eurprd02.prod.outlook.com ([fe80::2c1:6459:93f7:d2e4%6]) with mapi id 15.20.9891.019; Fri, 8 May 2026 07:50:32 +0000 Received: from DB9PR02MB6697.eurprd02.prod.outlook.com (2603:10a6:10:214::18) by PAXPR02MB7229.eurprd02.prod.outlook.com (2603:10a6:102:1c0::10) with Microsoft SMTP Server (version=TLS1_2, cipher=TLS_ECDHE_RSA_WITH_AES_256_GCM_SHA384) id 15.20.9846.18; Fri, 8 May 2026 07:50:33 +0000 Received: from VI6PPFA77322565.eurprd02.prod.outlook.com (2603:10a6:808:1::317) by DB9PR02MB6697.eurprd02.prod.outlook.com with HTTPS; Fri, 8 May 2026 07:50:39 +0000 Received: from DU2PR04CA0287.eurprd04.prod.outlook.com (2603:10a6:10:28c::22) by VI6PPFA77322565.eurprd02.prod.outlook.com (2603:10a6:808:1::317) with Microsoft SMTP Server (version=TLS1_2, cipher=TLS_ECDHE_RSA_WITH_AES_256_GCM_SHA384) id 15.20.9891.15; Fri, 8 May 2026 07:50:37 +0000 From: "MSO - RA" To: "Regionaalhaigla Info" , "kliinikumkliinikum.ee" , , , , , , , , , , , , , , , , , , "Mart Saluvere" , , "Gerli Raieste" Subject: Meditsiiniseadmete ohutusalane info - aprill 2026 Date: Fri, 8 May 2026 10:50:32 +0300 Keywords: Renate, Delta Message-ID: MIME-Version: 1.0 Content-Type: multipart/alternative; boundary="----=_NextPart_000_00EB_01DCEA1A.B95EA870" X-Mailer: Microsoft Outlook 16.0 Thread-Index: AQIxgaZ8H9vOxb8s1FltelbsHp71UA== X-MS-Has-Attach: X-MS-TNEF-Correlator: X-MS-Exchange-Organization-AuthSource: DB9PR02MB6697.eurprd02.prod.outlook.com X-MS-Exchange-Organization-AuthAs: Internal X-MS-Exchange-Organization-Network-Message-Id: 4dd7c2c4-6af1-42e9-e63f-08deacd67daf X-MS-Exchange-Transport-EndToEndLatency: 00:00:02.7284618 X-MS-Exchange-Processed-By-BccFoldering: 15.20.9891.016 X-Message-Completed: Fri, 15 May 2026 12:52:34 +0300 Content-Language: et acceptlanguage: et-EE, en-US x-ms-exchange-organization-originalclientipaddress: 90.191.175.194 x-ms-exchange-organization-originalserveripaddress: 10.167.242.152 X-OlkEid: 000000004C30E2D3CD34B4428531CBEB8A7CAB89070034AD76187591974DBF6C4F76951C873A0100030000000000B04CDEF8D3227A448511457FBBCE9C87000000000C06000068131B1821B85141A89D48FBCE8430D3 Authentication-Results: spf=pass (sender IP is 13.93.42.39) smtp.mailfrom=ravimiamet.ee; dkim=none (message not signed) header.d=none;dmarc=none action=none header.from=ravimiamet.ee; received-spf: Pass (protection.outlook.com: domain of ravimiamet.ee designates 13.93.42.39 as permitted sender) receiver=protection.outlook.com; client-ip=13.93.42.39; helo=westeu12-emailsignatures-cloud.codetwo.com; pr=C msip_labels: MSIP_Label_defa4170-0d19-0005-0004-bc88714345d2_Enabled=True;MSIP_Label_defa4170-0d19-0005-0004-bc88714345d2_SiteId=8fe098d2-428d-4bd4-9803-7195fe96f0e2;MSIP_Label_defa4170-0d19-0005-0004-bc88714345d2_SetDate=2026-05-08T07:50:32.469Z;MSIP_Label_defa4170-0d19-0005-0004-bc88714345d2_Name=All Employees (unrestricted);MSIP_Label_defa4170-0d19-0005-0004-bc88714345d2_ContentBits=1;MSIP_Label_defa4170-0d19-0005-0004-bc88714345d2_Method=Standard; x-ms-traffictypediagnostic: DB9PR02MB6697:EE_|PAXPR02MB7229:EE_|DB1PEPF000509F6:EE_|VI6PPFA77322565:EE_|DB9PR02MB6697:EE_ X-MS-Office365-Filtering-Correlation-Id: 4dd7c2c4-6af1-42e9-e63f-08deacd67daf X-MS-Exchange-Transport-CrossTenantHeadersStamped: VI6PPFA77322565 X-MS-Exchange-Transport-CrossTenantHeadersStamped: PAXPR02MB7229 X-MS-PublicTrafficType: Email X-Microsoft-Antispam: BCL:0;ARA:13230040|82310400026|35042699022|366016|31052699007|39142699007|921020|13003099007|18002099003|56012099003|8096899003|55112099003|41050700001; X-Microsoft-Antispam-Message-Info: 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 X-Forefront-Antispam-Report: CIP:13.93.42.39;CTRY:NL;LANG:et;SCL:1;SRV:;IPV:NLI;SFV:NSPM;H:westeu12-emailsignatures-cloud.codetwo.com;PTR:westeu12-emailsignatures-cloud.codetwo.com;CAT:NONE;SFS:(13230040)(82310400026)(35042699022)(366016)(31052699007)(39142699007)(921020)(13003099007)(18002099003)(56012099003)(8096899003)(55112099003)(41050700001);DIR:INT; X-MS-Exchange-CrossTenant-OriginalArrivalTime: 08 May 2026 07:50:36.4290 (UTC) X-MS-Exchange-CrossTenant-Network-Message-Id: 4dd7c2c4-6af1-42e9-e63f-08deacd67daf X-MS-Exchange-CrossTenant-Id: 8fe098d2-428d-4bd4-9803-7195fe96f0e2 X-MS-Exchange-CrossTenant-AuthSource: DB9PR02MB6697.eurprd02.prod.outlook.com X-MS-Exchange-CrossTenant-AuthAs: Internal X-MS-Exchange-CrossTenant-FromEntityHeader: HybridOnPrem X-Microsoft-Antispam-Untrusted: BCL:0;ARA:13230040|31052699007|366016|39142699007|921020|13003099007|8096899003|56012099003|55112099003|18002099003|41050700001; X-Microsoft-Antispam-Message-Info-Original: 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 X-Forefront-Antispam-Report-Untrusted: CIP:255.255.255.255;CTRY:;LANG:et;SCL:1;SRV:;IPV:NLI;SFV:NSPM;H:DB9PR02MB6697.eurprd02.prod.outlook.com;PTR:;CAT:NONE;SFS:(13230040)(31052699007)(366016)(39142699007)(921020)(13003099007)(8096899003)(56012099003)(55112099003)(18002099003)(41050700001);DIR:INT; X-MS-Exchange-Organization-ExpirationStartTime: 08 May 2026 07:50:36.4847 (UTC) X-MS-Exchange-Organization-ExpirationStartTimeReason: OriginalSubmit X-MS-Exchange-Organization-ExpirationInterval: 1:00:00:00.0000000 X-MS-Exchange-Organization-ExpirationIntervalReason: OriginalSubmit X-EOPAttributedMessage: 0 X-MS-Exchange-Organization-MessageDirectionality: Originating X-MS-Exchange-Transport-CrossTenantHeadersStripped: DB1PEPF000509F6.eurprd02.prod.outlook.com X-MS-Office365-Filtering-Correlation-Id-Prvs: c07ceb43-40f3-4e6c-3839-08deacd67b92 X-MS-Exchange-AtpMessageProperties: SA X-MS-Exchange-Organization-SCL: 1 X-MS-Exchange-ExternalInOutlookResult: NotEnabled X-Microsoft-Antispam-Mailbox-Delivery: ucf:0;jmr:0;auth:0;dest:I;ENG:(910005)(944506478)(944626604)(920097)(425001)(930201)(20251009189)(140003); X-Exchange-RoutingPolicyChecked: jsJQovzZThCU6/nBQvBNzx0Y0Fhxd9O02LOCv9gpCDmB2smNmk8P0A99a9eY9f8gaUAA80r5kiBeAoNo2yoX9p18wUYTpW4K3yHwmZ6RXHaSDX2Q67FmRE6KWEvv8UHtl0SBMe7cn6BPvMg9FYEizq/VBzolVlB16+f5gaOAYtv7N+Gze40lBWM1WhDbT7CWVb7kSInMuFPjNHTPIjHsX5TpEVwjdCHCVwae4Nr60djuznDPYu/jsqrVDcuOeDSGuSK7AIJQvdRbTjLeXikE0/J+ONqaoBOrz+oVpLfXYoejjCSBXgYM/xmkjxO2fO6P3QlxFS+PWDBxN02a6Z3abg== X-OrganizationHeadersPreserved: PAXPR02MB7229.eurprd02.prod.outlook.com X-CodeTwo-MessageID: 68fad98a-a9d8-4048-8b65-cea06fa4d7c3.20260508075035@westeu12-emailsignatures-cloud.codetwo.com X-CodeTwoProcessed: true X-MS-Exchange-Organization-AuthMechanism: 04 X-MS-Exchange-Organization-Recipient-P2-Type: Bcc X-CrossPremisesHeadersPromoted: DB1PEPF000509F6.eurprd02.prod.outlook.com X-CrossPremisesHeadersFiltered: DB1PEPF000509F6.eurprd02.prod.outlook.com X-OriginatorOrg: m1wmgpm3xrpm87txzdfw82by7.smtp.codetwo.online X-MS-Exchange-CrossTenant-OriginalAttributedTenantConnectingIp: TenantId=8fe098d2-428d-4bd4-9803-7195fe96f0e2;Ip=[13.93.42.39];Helo=[westeu12-emailsignatures-cloud.codetwo.com] This is a multipart message in MIME format. ------=_NextPart_000_00EB_01DCEA1A.B95EA870 Content-Type: text/plain; charset="utf-8" Content-Transfer-Encoding: 8bit Tere! Anname teada, et aprill 2026 meile teatatud meditsiiniseadmete valdkonna parandusmeetmete ülevaade on nüüd avaldatud Ravimiameti kodulehel ohutusalase teabe rubriigis: https://www.ravimiamet.ee/meditsiiniseadmed/ettevotjale/ohutusalane-teave. Meditsiiniseadme tootja (või levitaja) kohustus on viivitamatult teavitada oma kasutajaid parandusmeetmetest, mistõttu on enamik teateid Teile tõenäoliselt juba teada. Meie avaldame ülevaate Eestit puudutavatest juhtumitest dubleerivalt, et tagada teabe kättesaadavus kõigile. Teie küsimused on alati teretulnud. Parimate soovidega Renate Saare Ravimiamet meditsiiniseadmete osakond spetsialist Tel 7 374 140 renate.saare@ravimiamet.ee Nooruse 1 50411 Tartu www.ravimiamet.ee Selles e-kirjas sisalduv teave (kaasa arvatud manused) on mõeldud ametialaseks kasutamiseks ning seda võivad kasutada vaid e-kirja adressaadid. E-kirjas sisalduvat teavet ei tohi ilma saatja selgelt väljendatud loata edasi saata ega mis tahes viisil kolmandatele isikutele avaldada. Juhul, kui Te olete saanud käesoleva e-kirja eksituse tõttu, teavitage sellest koheselt saatjat ning kustutage e-kiri. This e-mail and any attachments transmitted may contain confidential and privileged information. If you are not the intended recipient, please notify the sender immediately by returning the e-mail and permanently deleting what you have recieved. Any dissemination or use of this information by a third person without permission is prohibited and may be illegal. ------=_NextPart_000_00EB_01DCEA1A.B95EA870 Content-Type: text/html; charset="utf-8" Content-Transfer-Encoding: quoted-printable

Tere!

 

Anname teada, et aprill 2026 meile teatatud = meditsiiniseadmete valdkonna parandusmeetmete =C3=BClevaade on = n=C3=BC=C3=BCd avaldatud Ravimiameti kodulehel ohutusalase teabe = rubriigis: https://www.ravimiamet.ee/meditsiiniseadmed/ettevotjale/ohutusalane= -teave.  

Meditsiiniseadme tootja (v=C3=B5i levitaja) kohustus = on viivitamatult teavitada oma kasutajaid parandusmeetmetest, = mist=C3=B5ttu on enamik teateid Teile t=C3=B5en=C3=A4oliselt juba teada. Meie avaldame =C3=BClevaate Eestit puudutavatest juhtumitest = dubleerivalt, et tagada teabe k=C3=A4ttesaadavus = k=C3=B5igile.

 

Teie k=C3=BCsimused on alati teretulnud.

 

 

Parimate soovidega

Renate Saare

Ravimiamet

meditsiiniseadmete osakond

spetsialist

Tel 7 374 140

renate.saare@ravimiamet.ee

 

Nooruse 1

50411 Tartu

www.ravimiamet.ee

 

Selles e-kirjas sisalduv teave (kaasa arvatud = manused) on m=C3=B5eldud ametialaseks kasutamiseks ning seda v=C3=B5ivad = kasutada vaid e-kirja adressaadid. E-kirjas sisalduvat teavet ei tohi ilma saatja selgelt v=C3=A4ljendatud loata edasi saata ega mis = tahes viisil kolmandatele isikutele avaldada. Juhul, kui Te olete saanud = k=C3=A4esoleva e-kirja eksituse t=C3=B5ttu, teavitage sellest koheselt = saatjat ning kustutage e-kiri.
This e-mail and any attachments = transmitted may contain confidential and privileged information.  = If you are not the intended recipient, please notify the sender immediately by returning the e-mail and permanently deleting what you = have recieved. Any dissemination or use of this information by a third = person without permission is prohibited and may be illegal.


------=_NextPart_000_00EB_01DCEA1A.B95EA870--